Callable Multi Barrier Reverse Convertible

Symbol: ABICTQ
ISIN: CH1390859309
Issuer:
Leonteq Securities
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Price Time-delayed price
05.12.25
22:15:01
- %
- %
CHF
Volume
0
0
nominal
Trading hours for this product: 8:00 – 21:45

Performance

Closing prev. day 57.58
Diff. absolute / % 0.00 0.00%

Determined prices

Last Price 52.46 Volume 15,000
Time 09:54:23 Date 29/09/2025

More Product Information

Core Data

Name Callable Multi Barrier Reverse Convertible
ISIN CH1390859309
Valor 139085930
Symbol ABICTQ
Quotation in percent Yes
Coupon p.a. 10.00%
Coupon Premium 9.61%
Coupon Yield 0.39%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached Yes (Novo Nordisk AS (B) - 04/04/2025)
COSI Product No
Exercise type American
Currency Swiss Franc
First Trading Date 05/11/2024
Date of maturity 05/05/2026
Last trading day 30/04/2026
Settlement Type Path-dependent
IRS 871m Potentially in scope for combined transactions
Currency safeguarded Yes
Pricing Dirty
Issuer Leonteq Securities

Key data

Sideways yield p.a. -

market maker quality Date: 03/12/2025

Average Spread -
Last Best Bid Price 44.40 %
Last Best Ask Price - %
Last Best Bid Volume 250,000
Last Best Ask Volume 0
Average Buy Volume 0
Average Sell Volume 0
Average Buy Value 0 CHF
Average Sell Value 0 CHF
Spreads Availability Ratio 0.00%
Quote Availability 109.86%

Underlyings

Name Lonza Group N Eli Lilly & Co. Novo Nordisk AS (B)
ISIN CH0013841017 US5324571083 DK0062498333
Price 543.20 CHF 870.00 CHF 41.3375 EUR
Date 05/12/25 17:30 27/11/25 09:00 05/12/25 22:59
Cap 532.60 CHF 829.74 USD 763.10 DKK
Distance to Cap 12 184.35 -457.3
Distance to Cap in % 2.20% 18.18% -149.54%
Is Cap Level reached No No No
Barrier 314.234 CHF 489.547 USD 450.229 DKK
Distance to Barrier 230.366 524.543 6.62101
Distance to Barrier in % 42.30% 51.73% 1.45%
Is Barrier reached No No Yes

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.